semaglutide weight loss marketing usa Campaign Bundle Are you ready for the
Description
What is a safer and cheaper way to lose weight than GLP-1 drugs?
With off-patent semaglutide and new oral brands emerging from 2026, pharma should leverage FMCG pricing expertise, invest in real-time tracking of patient persistence and switching behaviours, and target drivers of engagement and loyalty beyond price
Ryan OConnor, Professional Truck Driver (US)
A top NYC weight-loss doctor shared the surprising skin complication that hes encountered in patients using GLP-1 drugs like Ozempic.
